The medical-device giant is positioning its Hugo RAS system to compete with Intuitive Surgical's da Vinci systems.
Litigation over Medtronic Plc’s alleged scheme to avoid $100 million in deal payments by sabotaging sales of a reusable ...
With positive trial results in urology and hernia repair already under its belt, the company is getting closer to taking on ...
In the last decade, Medtronic (MDT) stock has returned a notable $52 Bil back to its shareholders through cold, hard cash via ...
Zacks Investment Research on MSN
Medtronic (MDT) Stock Dips While Market Gains: Key Facts
Medtronic (MDT) closed the most recent trading day at $94.21, moving -1.76% from the previous trading session. The stock's performance was behind the S&P 500's daily gain of 0.58%. At the same time, ...
Medtronic plc (NYSE:MDT) is included among the Top 15 Growth Stocks for Long-Term Investors. Medtronic plc (NYSE:MDT) stands ...
Medtronic (MDT) just announced the launch of a new clinical study in the U.S. that will test its Hugo robotic-assisted ...
GlobalData on MSN
Medtronic begins Embrace Gynecology study of Hugo RAS system
Medtronic has initiated the Embrace Gynecology study in the US to assess the Hugo robotic-assisted surgery (RAS) system's ...
Minneapolis-based Medtronic, a medical device provider, is using patient experiences to drive new technological and business strategies at its Applied Innovation Lab. Here are four things to know ...
The companies agreed to enhance access to technology from DASI, a leader in AI-driven predictive modeling and digital twin ...
Medtronic (NYSE:MDT) is set to give its latest quarterly earnings report on Wednesday, 2025-05-21. Here's what investors need to know before the announcement. Analysts estimate that Medtronic will ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results